Recombinant Anti-C. albicans x Anti-CD64 Bispecific Antibody (Minibody) (MiniB-023)

Recombinant Anti-C. albicans x Anti-CD64 Bispecific Antibody (Minibody) is designed to be expressed as the anti-C. albicans scFv fused to N-terminus of Knob-CH3 domain and the anti-CD64 scFv to the Hole-CH3 domain, or vice versa. The CH3 domains are further stabilized by C-terminal disulfide bonds. This BsAb can retarget of neutrophils to Candida albicans. It is designed for the research of Candida albicans infection therapy.

Datasheet INQUIRY

Specifications

Targets

C. albicans & CD64

Type

Minibody

Species Reactivity

Human

Application

FuncS; Promising therapeutic agent

Related Disease

Candida albicans infection

Targets

Target 1

C. albicans

Alternative Names

C. albicans; Candida albicans; Debaryomycetaceae; Candida

Target 2

CD64

Gene ID

2209

UniProt ID

P12314

Alternative Names

FCGR1A; Fc fragment of IgG receptor Ia; CD64; FCRI; CD64A; IGFR1; Cluster of Differentiation 64; FcγRI; FCGR1B; FCGR1C; immunoglobulin G Fc receptor high affinity I; Fc gamma RI

Our products and services are for research use only, and not for use in diagnostic or therapeutic procedures.

Online Inquiry

Related products of "C. albicans & CD64"

See other bsAb targets related to "CD64"

Customer Reviews and Q&As

There are currently no customer reviews or questions for Recombinant Anti-C. albicans x Anti-CD64 Bispecific Antibody (Minibody) (MiniB-023). Click the button below to contact us or submit your feedback about this product.

Recombinant Anti-C. albicans x Anti-CD64 Bispecific Antibody (Minibody) (CAT#: MiniB-023)

Specifications

Targets

Customer Reviews and Q&As